Biocon and South Korea Reach Exclusive Licensing Deal for Obesity Medication
The South Korean pharmaceutical company Handok and Biocon Limited signed an exclusive licensing and supply agreement to commercialize Biocon Limited's sophisticated, vertically integrated therapeutic product, Synthetic Liraglutide. Liraglutide is an…